FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

31007811000001109: Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Dec 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
95773801000001115 Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
95773901000001114 Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has active ingredient Ceftolozane false Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninfusion.intravenous ontology form and route true Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intravenous route true Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Is a Ceftolozane + Tazobactam true Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Plays role Antibacterial therapeutic role true Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Is a Ceftolozane + tazobactam false Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has specific active ingredient Tazobactam sodium true Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has specific active ingredient Ceftolozane sulfate false Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tazobactam true Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ceftolozane true Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has active ingredient Tazobactam false Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Is a Product containing ceftolozane and tazobactam false Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has basis of strength substance Tazobactam false Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has basis of strength substance Ceftolozane false Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has specific active ingredient Ceftolozane sulfate true Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Is a True Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Inferred relationship Existential restriction modifier
Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials 10 vial Has VMP True Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start